Sushmita Purkayastha1, Kaitlyn Maffuid2, Xiaojie Zhu3, Rong Zhang4,5, Peter B Raven6. 1. Department of Applied Physiology and Wellness, Simmons School of Education and Human Development, Southern Methodist University, 3101 University Blvd, Rm 118 A, Dallas, TX, 75205, USA. spurkayastha@smu.edu. 2. Department of Applied Physiology and Wellness, Simmons School of Education and Human Development, Southern Methodist University, 3101 University Blvd, Rm 118 A, Dallas, TX, 75205, USA. 3. Department of Statistics, Southern Methodist University, Dallas, TX, USA. 4. Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital, Dallas, TX, USA. 5. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. 6. Institute of Cardiovascular and Metabolic Diseases, University of North Texas Health Science Center, Fort Worth, TX, USA.
Abstract
PURPOSE: This preliminary study tested the hypothesis that the carotid baroreflex (CBR) mediated sympathoexcitation regulates cerebral blood flow (CBF) at rest and during dynamic exercise. METHODS: In seven healthy subjects (26 ± 1 years), oscillatory neck pressure (NP) stimuli of + 40 mmHg were applied to the carotid baroreceptors at a pre-determined frequency of 0.1 Hz at rest, low (10 ± 1W), and heavy (30 ± 3W) exercise workloads (WLs) without (control) and with α - 1 adrenoreceptor blockade (prazosin). Spectral power analysis of the mean arterial blood pressure (MAP), mean middle cerebral artery blood velocity (MCAV), and cerebral tissue oxygenation index (ScO2) in the low-frequency range (0.07-0.20 Hz) was estimated to examine NP stimuli responses. RESULTS: From rest to heavy exercise, WLs resulted in a greater than three-fold increase in MCAV power (42 ± 23.8-145.2 ± 78, p < 0.01) and an almost three-fold increase in ScO2 power (0.51 ± 0.3-1.53 ± 0.8, p = 0.01), even though there were no changes in MAP power (from 24.5 ± 21 to 22.9 ± 11.9) with NP stimuli. With prazosin, the overall MAP (p = 0.0017), MCAV (p = 0.019), and ScO2 (p = 0.049) power was blunted regardless of the exercise conditions. Prazosin blockade resulted in increases in the Tf gain index between MAP and MCAV compared to the control (p = 0.03). CONCLUSION: CBR-mediated changes in sympathetic activity contribute to dynamic regulation of the cerebral vasculature and CBF at rest and during dynamic exercise in humans.
PURPOSE: This preliminary study tested the hypothesis that the carotid baroreflex (CBR) mediated sympathoexcitation regulates cerebral blood flow (CBF) at rest and during dynamic exercise. METHODS: In seven healthy subjects (26 ± 1 years), oscillatory neck pressure (NP) stimuli of + 40 mmHg were applied to the carotid baroreceptors at a pre-determined frequency of 0.1 Hz at rest, low (10 ± 1W), and heavy (30 ± 3W) exercise workloads (WLs) without (control) and with α - 1 adrenoreceptor blockade (prazosin). Spectral power analysis of the mean arterial blood pressure (MAP), mean middle cerebral artery blood velocity (MCAV), and cerebral tissue oxygenation index (ScO2) in the low-frequency range (0.07-0.20 Hz) was estimated to examine NP stimuli responses. RESULTS: From rest to heavy exercise, WLs resulted in a greater than three-fold increase in MCAV power (42 ± 23.8-145.2 ± 78, p < 0.01) and an almost three-fold increase in ScO2 power (0.51 ± 0.3-1.53 ± 0.8, p = 0.01), even though there were no changes in MAP power (from 24.5 ± 21 to 22.9 ± 11.9) with NP stimuli. With prazosin, the overall MAP (p = 0.0017), MCAV (p = 0.019), and ScO2 (p = 0.049) power was blunted regardless of the exercise conditions. Prazosin blockade resulted in increases in the Tf gain index between MAP and MCAV compared to the control (p = 0.03). CONCLUSION: CBR-mediated changes in sympathetic activity contribute to dynamic regulation of the cerebral vasculature and CBF at rest and during dynamic exercise in humans.
Entities:
Keywords:
Cerebral blood vessels; Cerebral tissue oxygenation; Dynamic exercise; Power spectral density; Sympathetic activity; Transfer function gain
Authors: Rong Zhang; Julie H Zuckerman; Kenichi Iwasaki; Thad E Wilson; Craig G Crandall; Benjamin D Levine Journal: Circulation Date: 2002-10-01 Impact factor: 29.690
Authors: D Walter Wray; Paul J Fadel; David M Keller; Shigehiko Ogoh; Mikael Sander; Peter B Raven; Michael L Smith Journal: J Physiol Date: 2004-07-02 Impact factor: 5.182
Authors: Max J Hilz; Philip A DeFina; Stefan Anders; Julia Koehn; Christoph J Lang; Elisabeth Pauli; Steven R Flanagan; Stefan Schwab; Harald Marthol Journal: J Neurotrauma Date: 2011-04-21 Impact factor: 5.269
Authors: Max J Hilz; Julia Koehn; Alexandra Tillmann; Stephan Riss; Harald Marthol; Martin Köhrmann; Gerald Wasmeier; Stefan Schwab; Brigitte Stemper Journal: Stroke Date: 2013-02-19 Impact factor: 7.914